Skip to main content

Rehabilitation

0
Pipeline Programs
2
Companies
3
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Verona Pharma
Verona PharmaUK - London
2 programs
Cognitive rehabilitation: CG groupN/A1 trial
TelerehabilitationN/A1 trial
Active Trials
NCT06820125Recruiting48Est. Jul 2026
NCT06795672Terminated23Est. Mar 2024
ICU Medical
ICU MedicalCA - San Clemente
1 program
exercisesN/A1 trial
Active Trials
NCT05808361Completed180Est. Jun 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Verona PharmaCognitive rehabilitation: CG group
Verona PharmaTelerehabilitation
ICU Medicalexercises

Clinical Trials (3)

Total enrollment: 251 patients across 3 trials

NCT06820125Verona PharmaCognitive rehabilitation: CG group

Isolated Versus Combined Cognitive and Motor High-tech Rehabilitation

Start: Jul 2023Est. completion: Jul 202648 patients
N/ARecruiting
NCT06795672Verona PharmaTelerehabilitation

Tele-rehabilitation for Cognitive Disorders

Start: Mar 2022Est. completion: Mar 202423 patients
N/ATerminated

Rehabilitation Treatment of Patients With COVID-19

Start: Apr 2020Est. completion: Jun 2021180 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 251 patients
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.